Titre du document / Document title
Transbuccal permeation, anti-inflammatory activity and clinical efficacy of diroxicam formulated in different gels
Auteur(s) / Author(s)
ATTI M. A.
(1) ;
EL-GIBALY I.
(1) ;
SHALTOUT S. E.
(2) ;
FETIH G. N.
(1) ;
Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)
(1) Department of Pharmaceutics, Faculty of Pharmacy, Assim University, Assiut, EGYPTE
(2) Oral and Maxillofacial Surgery Section, Faculty of Medicine, Assiut University Hospital, Assiut University, Assiut, EGYPTE
Résumé / Abstract
In attempts to avoid the systemic side effects of piroxicam (PC) (e.g. gastrotoxicity), several buccal gel formulations containing PC were prepared and their effects on the characteristics of the drug permeation through rabbit buccal mucosa in-vitro were evaluated using a Franz-type diffusion cell. The general rank order of the total flux of 0.5% PC from gels was found to be: hydroxypropylmethylcellulose (HPMC, 2.5%) > hydroxypropylcellulose (HPC, 2.5%) > sodium alginate (Na alg., 7%) > methylcellulose (MC, 3%) > hydroxyethylcellulose (HEC, 1.5%) > carbopol 934 (Carb. 934, 1%) ≥ sodium carboxymethylcellulose (NaCMC, 2%) > pluronic F-127 (PF-127, 20%) > polyvinyl alcohol (PVA, 10%). The effect of various penetration enhancers 1% sodium lauryl sulphate (NaLS), 3% sodium deoxycholate (NaDC), 3% sodium tauroglycocholate (NaTGC) on the rate of permeation across the excised buccal mucosa (of 0.5% PC in gels prepared using 3% MC, 2.5% HPMC or 7% Na alg. base) and histology of the buccal epithelium was also investigated. Pharmacodynamic evaluation of the anti-inflammatory activity of PC in these gel formulations (containing 3% NaDC as an enhancer) was carried out using the kaolin-induced rat paw oedema method. The results obtained indicated that PC administered in 7% Na alg. or 2.5% HPMC gel bases was significantly more effective than the 3% MC gel and oral drug solution in suppressing oedema formation in rats. Comparative clinical studies were conducted in patients with post-operative dental pain and oedema following maxillofacial operations. The results revealed that 7% Na alg. and 2.5% HPMC gel formulations applied to the buccal mucosa were slightly better than or equally effective to the orally administered commercial product (Feldene Flash® tablet) in reducing pain level, swelling and tenderness within a period of 4 days. These findings suggest that PC (0.5%) administered in the buccal gel may present a potential therapeutical use as a strong anti-inflammatory and analgesic agent.
Revue / Journal Title
International journal of pharmaceutics
ISSN 0378-5173
CODEN IJPHDE
Source / Source
2004, vol. 276, n
o1-2, pp. 11-28 [18 page(s) (article)] (1 p.1/4)
Langue / Language
Anglais
Editeur / Publisher
Elsevier, Amsterdam, PAYS-BAS
(1978)
(Revue)
Mots-clés anglais / English Keywords
Enzyme ;
Oxidoreductases ;
Prostaglandin-endoperoxide synthase ;
Oxicam derivatives ;
Enzyme inhibitor ;
Rodentia ;
Vertebrata ;
Mammalia ;
Lagomorpha ;
Analgesic ;
Antipyretic ;
Rat ;
Penetration ;
Permeability ;
Mucosa ;
Rabbit ;
Animal ;
Piroxicam ;
Colloidal gel ;
Non steroidal antiinflammatory agent ;
Permeation ;
Mots-clés français / French Keywords
Enzyme ;
Oxidoreductases ;
Prostaglandin-endoperoxide synthase ;
Oxicam dérivé ;
Inhibiteur enzyme ;
Rodentia ;
Vertebrata ;
Mammalia ;
Lagomorpha ;
Analgésique ;
Antipyrétique ;
Rat ;
Pénétration ;
Perméabilité ;
Muqueuse ;
Lapin ;
Animal ;
Piroxicam ;
Gel colloïdal ;
Antiinflammatoire non stéroïde ;
Perméation ;
Mots-clés espagnols / Spanish Keywords
Enzima ;
Oxidoreductases ;
Prostaglandin-endoperoxide synthase ;
Oxicam derivado ;
Inhibidor enzima ;
Rodentia ;
Vertebrata ;
Mammalia ;
Lagomorpha ;
Analgésico ;
Antipirético ;
Rata ;
Penetración ;
Permeabilidad ;
Mucosa ;
Conejo ;
Animal ;
Piroxicam ;
Gel coloidal ;
Antiinflamatorio no esteroide ;
Permeación ;
Mots-clés d'auteur / Author Keywords
Piroxicam ;
Rabbit buccal mucosa ;
Buccal permeability ;
Penetration enhancer ;
Rat paw oedema ;
Localisation / Location
INIST-CNRS, Cote INIST : 16510, 35400011001907.0020
Nº notice refdoc (ud4) : 15724470